Mpox: Africa records over 61,000 cases as treatment research gains momentum
Africa is facing a severe mpox outbreak, with over 61,000 cases and nearly 300 deaths since 2024, highlighting an urgent need for effective treatments. In response, the Africa CDC-led MOSA clinical trial is actively evaluating potential therapies, now bolstered by a new collaboration with Emergent BioSolutions and PANTHER. This initiative represents a pivotal shift toward building autonomous, continent-wide research capacity to manage emerging health threats. The trial’s successful initial safety review marks significant progress in generating evidence
